Y-mAbs Therapeutics, Inc. (YMAB)
USD 8.78
(-7.87%)
USD 8.78
(-7.87%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -27.23 Million | -75.92 Million | -102.55 Million | -91.23 Million | -73.49 Million | -41.22 Million |
| Net Income | -21.42 Million | -95.56 Million | -55.27 Million | -119.33 Million | -81.02 Million | -43.27 Million |
| Depreciation & Amortization | 735 Thousand | 839 Thousand | 782 Thousand | 396 Thousand | 166 Thousand | 29 Thousand |
| Deferred income taxes | 15.14 Million | - | 1.89 Million | -576 Thousand | - | - |
| Stock-based compensation | 14.45 Million | 25.6 Million | 19.33 Million | 16.13 Million | 4.65 Million | 1.96 Million |
| Change in working capital | -19.73 Million | -10.37 Million | -7.28 Million | 3.44 Million | 2.66 Million | -47 Thousand |
| Other non-cash items | -16.4 Million | 3.57 Million | -62.01 Million | 8.7 Million | 43 Thousand | 97 Thousand |
| Investing Cash Flow | - | - | 61.04 Million | -2.78 Million | -1.96 Million | -234 Thousand |
| Investments in PPE | - | - | -967 Thousand | -175 Thousand | -1.96 Million | -234 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 62.01 Million | -2.61 Million | - | - |
| Financing Cash Flow | 100 Thousand | 84 Thousand | 108.31 Million | 2 Million | 134.7 Million | 98.76 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 100 Thousand | 84 Thousand | 107.72 Million | 2 Million | 134.7 Million | 99.76 Million |
| Other Financing Activities | 100 Thousand | 84 Thousand | 589 Thousand | 2 Million | 134.7 Million | -1 Million |
| Accounts receivables | -9.92 Million | -4.81 Million | -7.71 Million | -7.37 Million | - | - |
| Accounts payables | -6.85 Million | -919 Thousand | 4.18 Million | 852 Thousand | 2.61 Million | 1.26 Million |
| Inventory | 1.63 Million | -1.19 Million | -5.51 Million | 7.37 Million | - | - |
| Other working capital | -4.59 Million | -3.44 Million | 1.76 Million | 2.59 Million | 48 Thousand | -1.3 Million |
| Cash at beginning of period | 105.76 Million | 181.56 Million | 114.63 Million | 207.13 Million | 147.87 Million | 90.51 Million |
| Cash at end of period | 78.63 Million | 105.76 Million | 181.56 Million | 114.63 Million | 207.13 Million | 147.87 Million |
| Capital Expenditure | - | - | -967 Thousand | -175 Thousand | -1.96 Million | -234 Thousand |
| Effect of forex changes on cash | 7000.00 | 35 Thousand | 129 Thousand | -490 Thousand | 23 Thousand | 56 Thousand |
| Net cash flow / Change in cash | -27.12 Million | -75.8 Million | 66.93 Million | -92.5 Million | 59.26 Million | 57.35 Million |
| Free Cash Flow | -27.23 Million | -75.92 Million | -103.52 Million | -91.4 Million | -75.46 Million | -41.46 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.24 Million | -6.62 Million | -988 Thousand | -21.42 Million | -7.74 Million | -6.3 Million |
| Depreciation & Amortization | 153 Thousand | 159 Thousand | 161 Thousand | 735 Thousand | 168 Thousand | 224 Thousand |
| Deferred income taxes | - | - | -3.33 Million | 15.14 Million | 2.28 Million | 1.05 Million |
| Stock-based compensation | 3.43 Million | 3.84 Million | 3.12 Million | 14.45 Million | 2.49 Million | 3.61 Million |
| Change in working capital | 5.72 Million | -1.34 Million | -9.44 Million | -19.73 Million | 3.42 Million | -1.95 Million |
| Other non-cash items | 18.42 Million | 5.99 Million | 2.44 Million | -16.4 Million | -1.87 Million | -1.37 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.75 Million | 588 Thousand | 100 Thousand | 100 Thousand | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.75 Million | 588 Thousand | 100 Thousand | 100 Thousand | - | - |
| Other Financing Activities | 1.75 Million | 588 Thousand | 100 Thousand | 100 Thousand | - | - |
| Accounts receivables | -17.62 Million | 1.86 Million | -3.58 Million | -9.92 Million | 244 Thousand | -416 Thousand |
| Accounts payables | 3.23 Million | 176 Thousand | -660 Thousand | -6.85 Million | -47 Thousand | -1.37 Million |
| Inventory | -50 Thousand | -3.38 Million | 2.04 Million | 1.63 Million | -1.92 Million | 3.75 Million |
| Other working capital | 20.17 Million | -4000.00 | -7.25 Million | -4.59 Million | 5.15 Million | -3.91 Million |
| Cash at beginning of period | 75.74 Million | 78.63 Million | 86.57 Million | 105.76 Million | 87.9 Million | 92.62 Million |
| Cash at end of period | 77.8 Million | 75.74 Million | 78.63 Million | 78.63 Million | 86.57 Million | 87.9 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 1000.00 | 1000.00 | 2000.00 | 7000.00 | - | 14 Thousand |
| Net cash flow / Change in cash | 2.05 Million | -2.88 Million | -7.93 Million | -27.12 Million | -1.33 Million | -4.72 Million |
| Free Cash Flow | 298 Thousand | -3.47 Million | -8.03 Million | -27.23 Million | -1.33 Million | -4.73 Million |
OODH
EVLV
001685
8276
4445
AI